Xolair denied by insurance? Appeal and win.
An insurer's no on Xolair is seldom the end of the conversation, it usually marks a documentation gap that the policy itself tells you how to close. Because omalizumab is an anti-IgE biologic dosed off a strict serum-IgE and body-weight table, insurers most often reject it for a missing or out-of-range total IgE level, for asthma that is not yet documented as moderate-to-severe persistent on an inhaled corticosteroid plus LABA, or for chronic spontaneous urticaria without a recorded failure of H1 antihistamines at up-titrated doses. The appeal turns on supplying exactly what the policy demands: the in-range total serum IgE with weight to confirm the labeled dosing band, a positive perennial aeroallergen sensitivity test for the allergic-asthma indication, the right anchor code (J45.x for asthma, L50.1 for chronic spontaneous urticaria, J33.x for nasal polyps), and a clean prior-therapy log proving standard controllers fell short. Pin the request to Xolair's specific FDA-approved indication and the documentation transforms from a guess into a record the medical reviewer cannot dismiss.
Reviewed by the Apellica Appeals Team · Updated June 2026
Carrier names and logos are trademarks of their respective owners. Apellica is independent and not affiliated with any insurance carrier or carrier's appeal program.
Allergic asthma, chronic urticaria, and related conditions.
Why Xolair gets denied
- Step therapy through standard controller therapy
- Prior-authorization criteria not documented
- IgE level or diagnosis not evidenced
- Site-of-care restrictions
What a winning appeal includes
- Diagnosis with IgE or eosinophil documentation where required
- Prior controller therapies and outcomes
- Specialist support
- A letter of medical necessity
How we approach the appeal
Document controller-therapy failure and the supporting labs, and tie the request to the plan's criteria.
Xolair appeal letter template
Copy this Xolair appeal letter, fill in the brackets, and send it within your deadline. It is built on what overturns Anti-IgE biologic denials.
[Date] [Your name] · Member ID [ID] · Rx claim # [#] [Insurer or PBM] - Appeals Department Re: Appeal of Xolair denial I am appealing the denial of Xolair (omalizumab). I request that the denial be overturned and Xolair approved. 1. The denial. [Insurer] denied Xolair stating, verbatim: "[paste the exact denial reason from your letter]." 2. Medical necessity. Xolair is medically necessary for my condition. Document controller-therapy failure and the supporting labs, and tie the request to the plan's criteria. 3. Step-therapy or formulary exception (if that was the reason): I have tried and failed [preferred drug(s)], with pharmacy records attached, or the preferred alternative is contraindicated because [reason]. I request a formulary or step-therapy exception. 4. My request. Approve Xolair within the timeframe required by law. If the denial is upheld, please provide the specific criteria used, the reviewing clinician's credentials, and external-review instructions. Attached: prescriber letter of medical necessity, pharmacy and prior-trial records, and supporting clinical notes. Sincerely, [Your name]
Want it built and filed for you? Use the free generator, or have Apellica do it.
Internal appeals: 30 days pre-service, 60 days post-service, 72 hours urgent. File within 180 days.
$0 upfront. We assess fit first, then build and file the appeal for you.
- · The denial letter and your Explanation of Benefits (EOB)
- · Insurance ID, plan name, and the claim or prior-authorization number
- · Diagnosis with ICD-10 code and the prescriber's clinical notes
- · A record of treatments already tried and how they worked
Appealing a Xolair denial by insurer
The path depends on who manages your benefit. The most common:
Coverage runs through the pharmacy benefit. Appeal the coverage determination and, when the drug is non-formulary, file a formulary or tier exception with a provider attestation that covered alternatives are unsuitable.
Publishes detailed prior-authorization criteria. A denial usually means a criterion was not documented. Appeal through a coverage review, with a formulary exception for excluded drugs.
Administers many UnitedHealthcare and employer plans. Appeals and exceptions follow the plan's published PA criteria; expedited review exists for urgent cases.
Internal appeal first, then independent external review. Pre-service decisions are generally made within 30 days, urgent within 72 hours.
Internal appeals and external review; pharmacy denials often route through OptumRx criteria.
Independent state plans, so criteria vary. Match the appeal to your specific BCBS plan, internal appeal first, then external review.
Frequently asked questions
Why was Xolair denied?
Often because standard controllers were not documented as tried, or required lab values were missing.
Xolair denied? We fight it for you.
$0 upfront. Two-minute intake. We confirm fit and reply within one business day with the right path for your situation.
Start Your AppealThis page provides general information about appeal strategy. It is not legal or medical advice. Apellica is not a law firm. Outcomes depend on documentation, plan terms, and timing.